Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» oral semaglutide
oral semaglutide
Novo Nordisk’s trial of oral semaglutide meets primary endpoint
Clinical Trials Arena
Tue, 05/23/23 - 09:56 am
Novo Nordisk
semaglutide
oral semaglutide
clinical trials
weight loss
Novo Nordisk to launch PhIII obesity trial for oral semaglutide
Endpoints
Wed, 04/21/21 - 11:17 pm
Novo Nordisk
diabetes
obesity
semaglutide
oral semaglutide
clinical trials
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
Mon, 02/17/20 - 11:33 pm
drug launches
Biohaven
rimegepant
Novartis
ofatumumab
Celgene
ozanimod
Akebia Therapeutics
vadadustat
Biomarin
valrox
Gilead Sciences
filgotinib
Novo Nordisk
oral semaglutide
inclisiran
Immunomedics
sacituzumab govitecan
AstraZeneca
Enhertu
Bristol-Myers Squibb
liso-cel
ICER Warns of ‘Short-Term Budget Challenges’ with Novo’s Rybelsus
Xtalks
Tue, 12/10/19 - 10:35 am
Novo Nordisk
Rybelsus
oral semaglutide
diabetes
ICER
drug pricing
Novo drops oral GLP-1 analog to focus on next-gen Rybelsus
Fierce Biotech
Fri, 11/1/19 - 10:36 am
Novo Nordisk
diabetes
OG2023SC
Rybelsus
oral semaglutide
Novo’s new oral GLP-1 Rybelsus still has obstacles to overcome
Pharmaforum
Tue, 09/24/19 - 09:53 am
Novo Nordisk
oral semaglutide
Rybelsus
FDA
Novo Nordisk wins FDA green light for 'holy grail' diabetes drug Rybelsus
Fierce Pharma
Fri, 09/20/19 - 01:13 pm
Novo Nordisk
oral semaglutide
FDA
Rybelsus
type 2 diabetes
How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes Pedestal
Investors Business Daily
Wed, 09/18/19 - 09:53 am
Novo Nordisk
Eli Lilly
oral semaglutide
Trulicity
diabetes
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Yahoo/Benzinga
Sun, 09/15/19 - 10:05 pm
Merck
Pifeltro
FDA
Delstrigo
Novo Nordisk
oral semaglutide
Kodiak Sciences
MeiraGTx Holdings
IPOs
Exagen
IGM Biosciences
Arrowhead Pharmaceuticals
Lexicon Pharmaceuticals
Bluebird Bio
vTv Therapeutics
ICER dings Novo's new oral diabetes drug
Biopharma Dive
Wed, 09/11/19 - 11:41 pm
Novo Nordisk
diabetes
ICER
oral semaglutide
Eli Lilly
Boehringer Ingelheim
Jardiance
Ozempic
Novo Nordisk goes for broke on semaglutide heart data
Biopharma Dive
Tue, 06/11/19 - 06:01 pm
Novo Nordisk
diabetes
FDA
Ozempic
oral semaglutide
Novo Nordisk Trots Along Waiting for Its Next-Generation Oral Drug
Motley Fool
Thu, 05/9/19 - 11:20 pm
Novo Nordisk
earnings
diabetes
oral semaglutide
FDA